Advances in RIPK1 kinase inhibitors

Chen, L; Zhang, XQ; Ou, YQ; Liu, MY; Yu, DK; Song, ZH; Niu, LH; Zhang, LJ; Shi, JY

Zhang, LJ (通讯作者),Chengdu Univ Tradit Chinese Med, Coll Pharm, Chengdu, Peoples R China.;Shi, JY (通讯作者),Univ Elect Sci & Technol China, Sichuan Acad Med Sci, Personalized Drug Therapy Key Lab Sichuan Prov, Dept Pharm, Chengdu, Peoples R China.;Shi, JY (通讯作者),Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sch Med, Chengdu, Peoples R China.;Niu, LH (通讯作者),Acad Med Sci, Inst Lab Anim Sci, Chengdu, Sichuan, Peoples R China.;Niu, LH (通讯作者),Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peopl

FRONTIERS IN PHARMACOLOGY, 2022; 13 ():

Abstract

Programmed necrosis is a new modulated cell death mode with necrotizing morphological characteristics. Receptor interacting protein 1 (RIPK1) is a cri......

Full Text Link